Two unexpected courses in four children with lymphoblastic leukemia of B-cell type (B-ALL).

[1]  Denis R. Miller,et al.  LSA2–L2 protocol treatment of stage IV non‐hodgkin's lymphoma in children with partial and extensive bone marrow involvement , 2006, Cancer.

[2]  R. Gale,et al.  Recent advances in the biology and treatment of acute lymphoblastic leukemia in adults. , 1984, The New England journal of medicine.

[3]  G. Henze,et al.  Kindliche B-Zell-Lymphome und -Leukämien , 1984 .

[4]  Denis R. Miller,et al.  Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG‐141: A report from childrens cancer study group , 1983, Cancer.

[5]  G. Flandrin,et al.  Acute lymphoblastic leukemia with Burkitt's lymphoma cells: membrane markers and serum immunoglobulin. , 1981, Journal of the National Cancer Institute.

[6]  M. Andreeff,et al.  Heterogeneity of cell lineages in L3 leukemias. , 1980, Blood.

[7]  M. Greaves,et al.  ACUTE LYMPHOBLASTIC LEUKÆMIA IN CHILDREN: CLASSIFICATION AND PROGNOSIS , 1977, The Lancet.

[8]  David E. Irwin,et al.  Poor prognosis of children with acute lymphocytic leukemia and increased B cell markers. , 1976, The Journal of pediatrics.

[9]  G. Flandrin,et al.  Acute leukemia with Burkitt's tumor cells: A study of six cases with special reference to lymphocyte surface markers. , 1975, Blood.

[10]  A. Bluming,et al.  Bone Marrow Involvement in Burkitt's Lymphoma: Results of a Prospective Study , 1972, British journal of haematology.

[11]  E. Borden,et al.  Depression of interferon production after A.L.S. treatment. , 1969, Lancet.

[12]  H. Riehm.  Therapie der akuten lymphoblastischen Leukämie des Kindes , 1984 .